AI assistant
Hester Biosciences Ltd — Call Transcript 2023
Oct 30, 2023
62222_rns_2023-10-30_ee6433a2-36af-4267-960f-182aea3c3d1b.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [595 x 128] intentionally omitted <==
30 October 2023
To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 524669
To, National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051
Symbol: HESTERBIO
Dear Sir/ Madam:
Subject: Intimation of earnings conference call
This is to inform you that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has scheduled investor interaction through a teleconference call on Tuesday, 7 November 2023 at 2:00 p.m. (IST), post the announcement of unaudited financial results for the quarter and half year ended 30 September 2023. Details for joining the call are attached herewith.
You are requested to take the above on record.
Sincerely For Hester Biosciences Limited
VINOD Digitally signed by VINOD MALI Date: 2023.10.30 MALI 14:37:26 +05'30'
Vinod Mali Company Secretary & Compliance Officer
Enclosure: As above
==> picture [198 x 32] intentionally omitted <==
is pleased to invite you to the
Q2 & H1FY24 Results Conference Call
of
==> picture [73 x 73] intentionally omitted <==
Hester Biosciences Limited
Represented by \
Mr. Rajiv Gandhi, CEO & Managing Director Ms. Priya Gandhi, Executive Director Mr. Nikhil Jhanwar, Chief Financial Officer
on
Tuesday, November 7, 2023 at 14:00 hrs India Time
Diamond Pass registration link: Copy this Link in your browser: Link
Call Co-ordinator:
Mr. Abdulkader Puranwala: Phone: +91 22 6807 7339, e-mail: [email protected]
For any clarification, please contact:
Mr. Rushad Kapadia: Phone: +91 22 6807 7334, e-mail: [email protected] Ms. Divya Purohit: Phone: +91 22 6807 7454, e-mail: [email protected] Ms. Seema Sehgal: Phone: +91 11 4221 8511, e-mail: [email protected]